The Importance of Supply Security

The COVID-19 pandemic worldwide has caused immense strain on the pharmaceutical supply chain.

Current realities include:
 

  • Increased sensitivity over origins of Active Pharmaceutical Ingredients (API).

  • Providing transparency over sourcing of Key Starting Materials (KSM) - origins, gluten/lactose/dye free.

  • Heightened transparency over adequate supply of API and safety stock.

  • Remote working.

  • Strain on IT/Communications Systems.

  • Serialization readiness. 

  • Customers increasing interest in diversifying their supply risk with high volume categories (e.g. women’s health – thyroid) to minimize service disruptions with incumbent suppliers.

Provell Pharmaceuticals stands ready to meet and exceed these expectations of our customers and patients. 

Provell is committed to:
 

  • Only source products with API/KSM from countries within Europe.

  • Maintain at minimum an adequate supply of product to meet existing demand and allocate additional stock to cover for potential supply disruptions (‘levo-insurance’).

  • Utilize high quality standards and control in the manufacturing and distribution of our products throughout the United States and Puerto Rico.

Learn how Provell is providing the United States the leading dispensed brand [1] of levothyroxine worldwide at a generic price to mitigate supply chain risk in these challenging times.

[1] Source: Data on file – IQVIA Q2 March 2019

1801 Horseshoe Pike - Suite 1, Honey Brook, PA 19344, USA 
101 Hudson Street - 21st Floor - Suite 2100, Jersey City, NJ 07302 USA

(Main) 610.942.8970  (Fax) 610.942.8973

info@provellpharma.com

LinkedIn Logo Image.png

©2020 by Provell Pharmaceuticals, LLC
No use of any Provell Pharmaceuticals trademark, trade name, or trade dress in this site may be made without the prior written authorization of Provell Pharmaceuticals, LLC, except to identify the product or services of the company.

Provell Horizontal Logo.v2.2017.PNG